Replies to post #102247 on Cytodyn Inc (CYDY)

[Black-Ops]

I agree. Agreements based on the December HIV deal but with better terms. This is the deal that moved CYDY from 32 cents to 1.50$ high, back to around 80 cents low. The rest is history.

We will likely have separate agreements with many Big Pharma Companies. for them to use their distribution abilities and our Leron.

Think Big Picture. Some might think of this as a Huge Picture.

[The oNiOnHEAd]

I don't see how Cytodyn is going to meet demand. After leronlimab is approved and can be used off-label, I think the demand is going to soar. Even without off-label use, supplies will not be able to meet global demand. Soon enough, leronlimab will be rationed and allocated to Covid-19 patients. This is really a shame, as many other patients could benefit greatly from it. That issue aside, each PR that says 1, 3, 5, etc. million more doses are being introduced into the pipeline - well, each one of those PRs is going to take the share price to the next level (excuse the phrase). You won't even have to watch a chart to get a mental picture of the trajectory - just listen for news on the next incoming batch, and the latest indication.